Clinical trial of vestibular therapy to reduce falls in patients with Alzheimer's disease
前庭疗法减少阿尔茨海默病患者跌倒的临床试验
基本信息
- 批准号:10611308
- 负责人:
- 金额:$ 51.49万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-02-15 至 2023-07-31
- 项目状态:已结题
- 来源:
- 关键词:AdherenceAdultAdverse eventAffectAgeAlzheimer&aposs DiseaseAlzheimer&aposs disease patientBlindedBrainCalendarCaregiversClinical ResearchClinical TrialsCognitionCognitiveCompensationDataEffectivenessElderlyEnrollmentEquilibriumEventExerciseFosteringGaitGoalsHeadHigh PrevalenceHospitalizationImpaired cognitionImpairmentInfrastructureInjuryInstitutionalizationInterventionLabyrinthMapsMeasuresMediatingMemoryMorbidity - disease rateMulticenter TrialsObservational StudyOperative Surgical ProceduresOutcomeParticipantPatient RecruitmentsPatientsPharmaceutical PreparationsPhasePhysical therapyPhysiologyPlayPositioning AttributePrevalencePublic HealthRandomizedRandomized, Controlled TrialsRehabilitation therapyResearchResearch AssistantResourcesRiskRisk FactorsRoleRotationSamplingSensorySystemTestingVestibular lossWorkactive controlclinical practiceclinically significantcognitive skillcomorbiditycomparative efficacydesigneffective interventionexperiencefall riskfallsfollow-upimprovedinnovationmortalitynovelpilot trialprospectiverandomized, clinical trialsrecruittreatment center
项目摘要
Project summary
Patients with Alzheimer’s disease (AD) are known to have greater balance and gait impairment and double
the rate of falls relative to healthy older adults (60-70% vs ~30%). Currently, few effective interventions
exist to manage and mitigate falls in AD, and unfortunately, falls continue to be one of the primary drivers of
morbidity, institutionalization, and mortality among AD patients. Recent studies have shown that AD patients
have a two-fold higher prevalence of vestibular impairment (~50%) relative to age-matched controls (~25%
prevalence). Additionally, in pilot data from an ongoing observational study, we have shown that vestibular
loss is associated with an increased rate of falls in AD patients. Vestibular therapy (VT) is a well-established
treatment for vestibular loss, and consists of physical therapy-based exercises designed to foster
compensation for reduced vestibular function. VT is effective in improving balance and reducing fall risk in
cognitively-intact patients with vestibular impairment. However, whether VT could be effective in improving
balance and reducing falls in AD patients with vestibular loss has never been explored. In this study, we
propose a randomized controlled trial of VT in 100 patients with mild-moderate AD who have vestibular
impairment. We will randomize patients 1:1 to a standard course of VT (1 session per week for 8 weeks) or
to an active control matched for effort and duration. We will compare the efficacy of VT vs. active control
primarily on 1-year incident fall rate. We will also investigate potential intermediate outcomes between VT
and falls – specifically balance outcomes (a predicted target of VT) and spatial cognitive outcomes (a novel
target of VT) – to understand potential mechanisms by which VT may influence fall rates. We hypothesize
that VT will have preliminary efficacy in reducing 1-year incident fall rates relative to an active control
intervention in a convenience sample of 100 patients with mild-moderate AD. We will also explore whether
VT has preliminary efficacy in improving balance and cognition relative to the active control intervention.
To accomplish the proposed study, we will recruit 100 patients from the Memory and Alzheimer’s
Treatment Center, a well-established AD clinical research resource at Johns Hopkins. Falls are a
disastrous outcome in patients with AD. If this pilot trial followed by a Phase III multi-center trial provide
strong evidence for the benefit of VT in reducing falls, this low-risk intervention could be widely
disseminated and implemented by an existing workforce and infrastructure, and produce substantial,
sustained change in AD clinical practice.
项目总结
众所周知,阿尔茨海默病(AD)患者的平衡和步态障碍较大,
跌倒的比率相对于健康的老年人(60%-70%对30%)。目前,几乎没有有效的干预措施
存在管理和减轻AD跌倒的风险,不幸的是,跌倒仍然是AD的主要驱动因素之一
AD患者的发病率、制度化和死亡率。最近的研究表明,AD患者
前庭功能障碍的患病率(~50%)是年龄匹配的对照组(~25%)的两倍
流行率)。此外,在一项正在进行的观察性研究的试点数据中,我们已经表明,前庭
丢失与AD患者跌倒的比率增加有关。前庭疗法(VT)是一种久负盛名的
前庭缺失的治疗,包括以物理治疗为基础的练习,旨在促进
前庭功能减退的补偿。VT在改善平衡和降低跌倒风险方面是有效的
前庭功能受损的认知功能正常的患者。然而,VT能否有效地改善
前庭缺失的AD患者的平衡和减少跌倒的研究从未被探索过。在这项研究中,我们
建议对100例有前庭症状的轻中度AD患者进行VT的随机对照试验
减损。我们将以1:1的比例将患者随机分配到标准的VT疗程(每周1次,共8周)或
一种在努力和持续时间上相匹配的主动对照。我们将比较VT和主动控制的效果
主要是关于1年事故的下落率。我们还将调查VT之间潜在的中间结果
和跌倒--特别是平衡结果(VT的预测目标)和空间认知结果(一种新的
VT的靶点)-了解VT可能影响跌倒速度的潜在机制。我们假设
与主动控制相比,VT在降低1年事故跌倒发生率方面具有初步效果
对100例轻中度阿尔茨海默病患者进行方便抽样干预。我们还将探索是否
与主动控制干预相比,室性早搏在改善平衡和认知方面具有初步疗效。
为了完成这项拟议的研究,我们将从记忆和阿尔茨海默病患者中招募100名患者
治疗中心,约翰霍普金斯大学著名的AD临床研究资源。瀑布是一种
阿尔茨海默病患者的灾难性后果。如果在第三阶段多中心试验之后进行该试点试验
强有力的证据表明,VT在减少跌倒方面有好处,这种低风险的干预措施可能会得到广泛应用
由现有的劳动力和基础设施传播和实施,并产生大量、
AD临床实践的持续变化。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Yuri Agrawal其他文献
Yuri Agrawal的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Yuri Agrawal', 18)}}的其他基金
Impact of vestibular loss on central vestibular pathways in aging adults
前庭丧失对老年人中枢前庭通路的影响
- 批准号:
10274617 - 财政年份:2021
- 资助金额:
$ 51.49万 - 项目类别:
Impact of vestibular loss on central vestibular pathways in aging adults
前庭丧失对老年人中枢前庭通路的影响
- 批准号:
10487441 - 财政年份:2021
- 资助金额:
$ 51.49万 - 项目类别:
Impact of vestibular loss on central vestibular pathways in aging adults
前庭丧失对老年人中枢前庭通路的影响
- 批准号:
10643891 - 财政年份:2021
- 资助金额:
$ 51.49万 - 项目类别:
Clinical trial of vestibular therapy to reduce falls in patients with Alzheimer's disease
前庭疗法减少阿尔茨海默病患者跌倒的临床试验
- 批准号:
10341139 - 财政年份:2021
- 资助金额:
$ 51.49万 - 项目类别:
Impact of vestibular loss on central vestibular pathways in aging adults
前庭丧失对老年人中枢前庭通路的影响
- 批准号:
10990150 - 财政年份:2021
- 资助金额:
$ 51.49万 - 项目类别:
Clinical trial of vestibular therapy to reduce falls in patients with Alzheimer's disease
前庭疗法减少阿尔茨海默病患者跌倒的临床试验
- 批准号:
10993253 - 财政年份:2021
- 资助金额:
$ 51.49万 - 项目类别:
Contribution of sensorimotor function to risk and pathogenic mechanisms of Alzheimer's disease and related dementias
感觉运动功能对阿尔茨海默病和相关痴呆的风险和致病机制的贡献
- 批准号:
10318172 - 财政年份:2019
- 资助金额:
$ 51.49万 - 项目类别:
Contribution of sensorimotor function to risk and pathogenic mechanisms of Alzheimer's disease and related dementias
感觉运动功能对阿尔茨海默病和相关痴呆的风险和致病机制的贡献
- 批准号:
10534237 - 财政年份:2019
- 资助金额:
$ 51.49万 - 项目类别:
Does vestibular loss predict falls in patients with Alzheimer's Disease?
前庭丧失是否预示着阿尔茨海默病患者会跌倒?
- 批准号:
9915832 - 财政年份:2018
- 资助金额:
$ 51.49万 - 项目类别:
Does vestibular loss predict falls in patients with Alzheimer's Disease?
前庭丧失是否预示着阿尔茨海默病患者会跌倒?
- 批准号:
9763435 - 财政年份:2018
- 资助金额:
$ 51.49万 - 项目类别:
相似海外基金
Co-designing a lifestyle, stop-vaping intervention for ex-smoking, adult vapers (CLOVER study)
为戒烟的成年电子烟使用者共同设计生活方式、戒烟干预措施(CLOVER 研究)
- 批准号:
MR/Z503605/1 - 财政年份:2024
- 资助金额:
$ 51.49万 - 项目类别:
Research Grant
Early Life Antecedents Predicting Adult Daily Affective Reactivity to Stress
早期生活经历预测成人对压力的日常情感反应
- 批准号:
2336167 - 财政年份:2024
- 资助金额:
$ 51.49万 - 项目类别:
Standard Grant
RAPID: Affective Mechanisms of Adjustment in Diverse Emerging Adult Student Communities Before, During, and Beyond the COVID-19 Pandemic
RAPID:COVID-19 大流行之前、期间和之后不同新兴成人学生社区的情感调整机制
- 批准号:
2402691 - 财政年份:2024
- 资助金额:
$ 51.49万 - 项目类别:
Standard Grant
Migrant Youth and the Sociolegal Construction of Child and Adult Categories
流动青年与儿童和成人类别的社会法律建构
- 批准号:
2341428 - 财政年份:2024
- 资助金额:
$ 51.49万 - 项目类别:
Standard Grant
Elucidation of Adult Newt Cells Regulating the ZRS enhancer during Limb Regeneration
阐明成体蝾螈细胞在肢体再生过程中调节 ZRS 增强子
- 批准号:
24K12150 - 财政年份:2024
- 资助金额:
$ 51.49万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Understanding how platelets mediate new neuron formation in the adult brain
了解血小板如何介导成人大脑中新神经元的形成
- 批准号:
DE240100561 - 财政年份:2024
- 资助金额:
$ 51.49万 - 项目类别:
Discovery Early Career Researcher Award
RUI: Evaluation of Neurotrophic-Like properties of Spaetzle-Toll Signaling in the Developing and Adult Cricket CNS
RUI:评估发育中和成年蟋蟀中枢神经系统中 Spaetzle-Toll 信号传导的神经营养样特性
- 批准号:
2230829 - 财政年份:2023
- 资助金额:
$ 51.49万 - 项目类别:
Standard Grant
Usefulness of a question prompt sheet for onco-fertility in adolescent and young adult patients under 25 years old.
问题提示表对于 25 岁以下青少年和年轻成年患者的肿瘤生育力的有用性。
- 批准号:
23K09542 - 财政年份:2023
- 资助金额:
$ 51.49万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Identification of new specific molecules associated with right ventricular dysfunction in adult patients with congenital heart disease
鉴定与成年先天性心脏病患者右心室功能障碍相关的新特异性分子
- 批准号:
23K07552 - 财政年份:2023
- 资助金额:
$ 51.49万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Issue identifications and model developments in transitional care for patients with adult congenital heart disease.
成人先天性心脏病患者过渡护理的问题识别和模型开发。
- 批准号:
23K07559 - 财政年份:2023
- 资助金额:
$ 51.49万 - 项目类别:
Grant-in-Aid for Scientific Research (C)